YOU ARE HERE: LAT HomeCollectionsMenopause


July 17, 1989 | From staff and wire reports
Delivering estrogen through a melt-in-your-mouth tablet reduces the hot flashes of menopause without risking liver damage from larger doses that are required for pills that are swallowed, a study at the University of Southern California reports. The tablet dissolves over three to five minutes while held in the buccal, or hollow, cavity of the cheek. This allows the estrogen to enter the bloodstream through the cheek's mucous membrane rather than through the digestive system.
July 7, 2005
Re "A Question for the Ages: To De-Bag or Not," Commentary, July 5: As I sat in the middle of the post-Fourth of July block party debris, sipping my morning coffee and musing over the previous day's family conversations, I chuckled out loud at the reflections of Dinah Lenney and her puffy eyes. Unlike her mother, I work hard at pumping up the self-esteem of my six now-adult hatchlings and their spouses, and they still think I'm wrong or unhelpful most of the time. Lenney's theory about 11-year-old girls being as fully realized as they will ever be again until after menopause is wonderful.
The new product was launched earlier this year in a fashion typical of top-notch pharmaceuticals: Fourteen years of studies, $25 million spent on research and development, 30 clinical trials ongoing worldwide and a $5-million marketing campaign featuring nationally known doctors as spokespeople. Only this is not a typical medication. Promensil, which was introduced in the United States in April, is a so-called "natural product" for the relief of menopausal symptoms.
France's conservative government said Wednesday that it will seek to impose strict controls on artificial impregnation, including a requirement that infertile couples have the consent of the sperm donor and a judge's permission before receiving an embryo implant. The government was spurred by a growing national debate this week following the birth of twins to a 59-year-old, post-menopausal British woman, who received an embryo implant at an Italian clinic.
May 16, 2011 | Yolanda Reid Chassiakos
"Fish out of water," Gladys said with pride as she took a seat in my office. "That's me. " No question, this full-figured, conservatively dressed woman in her 50s with salt-and-pepper hair was far different from most of her young and trendy screenwriting program classmates. Her past year had been a rough one: The unwelcome dissolution of her marriage of two decades and the departure of her adult children for higher education and work had fully emptied her nest. For the first time in more than 20 years, Gladys had no one to care for but herself.
June 24, 2007
Re "Doctors change course again on estrogen therapy," June 21 The Times' dramatic lead story on the latest findings from the Women's Health Initiative study creates the misimpression that there will be an important shift in treatment patterns based on this report. Although the data are reassuring in regard to heart disease risk from estrogen replacement in early menopause, the overall treatment issues in any given woman involve much more than just heart disease risk. As the article states, this study will primarily serve to reinforce the current standard practice: that estrogen should be used only for menopausal symptoms and that a low dose for the shortest treatment period is optimal.
May 29, 1989 | From staff and wire reports
Most married women in their 60s not only desire sex but engage in it an average of five times a month, a survey of older women shows. "The news is good for all of us as we approach our 65th birthdays," said Dr. Gloria A. Bachman, a gynecologist at the University of Medicine and Dentistry of New Jersey. "We found sex is alive and well in older women." Bachman, in a report presented last week to the American College of Obstetricians and Gynecologists, said 59 older women were surveyed.
Calcium supplements can retard bone loss associated with osteoporosis, but only in older women who have been postmenopausal for at least five years and who have calcium-deficient diets, a study published in Thursday's New England Journal of Medicine reveals. Among women who have been postmenopausal five years or less, calcium supplements appear ineffective in preventing a very rapid phase of bone loss, said Dr.
December 14, 2008 | Associated Press
Taking menopause hormones for five years doubles the risk for breast cancer, according to a new analysis of a big federal study that reveals the most dramatic evidence yet of the dangers of these popular pills. Even women who took estrogen and progestin pills for just a couple of years had a greater chance of getting cancer. But when they stopped, their odds quickly improved, returning to a normal risk level about two years later.
March 26, 2001 | From Washington Post
Women who take the hormone estrogen for 10 years or more after menopause substantially increase their risk of dying of ovarian cancer compared with women who do not take the hormone, according to a study released Tuesday. In the American Cancer Society study of more than 211,000 post-menopausal women, those with any history of using hormone replacement therapy had a somewhat higher death rate from ovarian cancer than nonusers.
Los Angeles Times Articles